从第一个用于创烧伤治疗的基因工程国家一类新药研发与转化应用看创烧伤治疗“中国方案”的创立  

Establishment of"Chinese way"for trauma and burn management based on the engineered growth factors research and application

作　　者：付小兵[1,2] 李校堃 Fu Xiaobing;Li Xiaokun(Research Center for Wound Repair and Tissue Regeneration,Medical Innovation Research Department,the PLA General Hospital,Beijing 100853,China;The Key Laboratory of PLA Wound Repair and Tissue Regeneration,the Fourth Medical Center of PLA General Hospital,Beijing 100048,China;School of Pharmaceutical Sciences,Wenzhou Medical University,Wenzhou 325035,China)

机构地区：[1]解放军总医院医学创新研究部创伤修复与组织再生研究中心,北京100853 [2]解放军总医院第四医学中心全军创伤修复与组织再生重点实验室,北京100048 [3]温州医科大学药学院

出　　处：《中华烧伤与创面修复杂志》2022年第1期4-8,共5页Chinese Journal of Burns And Wounds

摘　　要：创新与转化应用是近年来国内科学界反复讨论的重要话题。本文系统回顾生长因子研发和在我国创烧伤治疗中的应用过程及基于具有中国特色的创面治疗学科体系建设过程中形成创烧伤治疗“中国方案”的感悟和体会。希望这些弥足珍贵的历程能够对同行,特别是对青年一代具有一定的借鉴和启示作用。Innovation and translation application are important topics that have been discussed repeatedly in national community of science and technology in recent years.We do a systemic review about the research and development history of growth factors,their application in trauma and burn management in China,and the conception and experience about the establishment of"Chinese way"for trauma and burn management in the process of constructing a disciplinary system for wound treatment with Chinese characteristics.It is our hope that these precious experiences will provide references and inspiration to our peers,especially the young generation in their research.

关 键 词：创伤和损伤 烧伤 基因工程 生长因子 

分 类 号：R644[医药卫生—外科学]